NSW Pharm Group - Supply & changes medicine manufacture

NSW Pharm Group - Supply & changes medicine manufacture
Ingredient supply and change of sources for medicine manufacture

RACI NSW Pharmaceutical Sciences Group 

Ingredient Supply and Change of Sources for Medicine Manufacture

Monday 7 December at 2.00 to 4.00pm AEDT

Last April the Pharm group organised a webinar as to how Covid-19 was affecting medicine manufacture and test facilities and the supply chain.  It was hoped by all and indeed expected by many that life would be back to “normal” by November 2020.  Six months onwards it is apparent that there is no immediate reversal to our current practices and challenges and that longer term planning and implementation of changes are necessary.

This applies especially to the supply chain of medicines themselves and ingredients and components for their manufacture in Australia.

Projected and real shortages of supply of materials from overseas pose an on-going challenge to Australian medicine manufacturers and suppliers, resulting in real and potential critical supply to the consumer.

Dr Felicity Jameson, and Dr Karen Loft from TGA Pharmaceutical Chemistry Variations Section will cover supply issues for Australian companies and the regulatory activities taken to address them.

Rebecca Lee of Merck will update her April presentation, based upon the experiences of the past 6 months and project future supply of medicinal and other chemicals and biologicals.

At this time of writing, a presenter from a manufacturer or supplier has yet to be confirmed.


Presentation 1

ARTG Variations to support market supply: TGA’s experience with prescription medicines during COVID-19

Dr Felicity Jameson, Section Head, Dr Karen Loft Principal Evaluator

Pharmaceutical Chemistry Variations Section, TGA


Presentation 2

Medicines manufacturer perspective

To be advised


Presentation 3

6 Months on – lessons learned and the future - Perspective from a Life Science industry supplier & leader: Merck

 Rebecca Lee, ANZ Managing Director, Merck


Webinar moderator and host:

Scott Colbourne, Chair, RACI Pharmaceutical Science Group (NSW)

Customer Engagement Solution Owner, ALS



Follow the instructions and which fields to complete as an RACI member or non-member with care.  Members with an RACI account should enter their Username and Password and follow subsequent instructions.  Non-members will initially need to “Create a new account” and also follow subsequent instructions.


A $20 charge will be made for RACI and ARCS members, $10 for RACI student members and $30 for non-members for this webinar.

ARCS members, please contact davidaedmonds@yahoo.com.au to organise registration by COB Wednesday 2 December.  Please include ARC membership number.


Registrations close at 12 noon, Friday 4 December.  Links to the meeting will be subsequently issued to registrants.


For any queries on registration, please contact the NSW Branch coordinator, Claire Jung, Tuesday to Thursday,  email raci-nsw@raci.org.au or Mrs Pam Chantrell, Qld Branch coordinator, phone 0499 550 306.


If you have any queries you would like discussed please send them to davidaedmonds@yahoo.com by COB Wednesday 2 December to be passed on to the presenters.  

Please also note that previous Pharm Group Covid-19 webinars are:


12/7/2020 2:00 PM - 4:00 PM

If you haven't done so already you have to sign into the site before you can register for an event.


Event Registration


If you haven't done so already you have to sign into the site before you can register for an event.

If you are an RACI member or have been to an event in the past you are already in the system and just have to input your username [normally your email address] and your password.

 If this is your first time you need to click on the "create account" tab and follow the prompts.



Sign In

You may also be interested in